- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Postoperative Nausea and Vomiting (PONV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Postoperative Nausea and Vomiting (PONV) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Postoperative Nausea and Vomiting (PONV) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Serotonin Antagonists segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Postoperative Nausea and Vomiting (PONV) include Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, and Camurus, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Postoperative Nausea and Vomiting (PONV) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by players, this report covers
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Postoperative Nausea and Vomiting (PONV) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Postoperative Nausea and Vomiting (PONV), with revenue, gross margin and global market share of Postoperative Nausea and Vomiting (PONV) from 2019 to 2022.
Chapter 3, the Postoperative Nausea and Vomiting (PONV) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Postoperative Nausea and Vomiting (PONV) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Postoperative Nausea and Vomiting (PONV) research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Postoperative Nausea and Vomiting (PONV)
1.2 Classification of Postoperative Nausea and Vomiting (PONV) by Type
1.2.1 Overview: Global Postoperative Nausea and Vomiting (PONV) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type in 2021
1.2.3 Serotonin Antagonists
1.2.4 Steroids
1.2.5 Dopamine Antagonists
1.2.6 NK-1 Receptor Antagonists
1.2.7 Non-pharmacologic Treatment
1.2.8 Others
1.3 Global Postoperative Nausea and Vomiting (PONV) Market by Application
1.3.1 Overview: Global Postoperative Nausea and Vomiting (PONV) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Postoperative Nausea and Vomiting (PONV) Market Size & Forecast
1.5 Global Postoperative Nausea and Vomiting (PONV) Market Size and Forecast by Region
1.5.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region, (2017-2022)
1.5.3 North America Postoperative Nausea and Vomiting (PONV) Market Size and Prospect (2017-2028)
1.5.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size and Prospect (2017-2028)
1.5.6 South America Postoperative Nausea and Vomiting (PONV) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Postoperative Nausea and Vomiting (PONV) Market Drivers
1.6.2 Postoperative Nausea and Vomiting (PONV) Market Restraints
1.6.3 Postoperative Nausea and Vomiting (PONV) Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Acacia Pharma
2.1.1 Acacia Pharma Details
2.1.2 Acacia Pharma Major Business
2.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Acacia Pharma Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Ani Pharmaceuticals
2.4.1 Ani Pharmaceuticals Details
2.4.2 Ani Pharmaceuticals Major Business
2.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Ani Pharmaceuticals Recent Developments and Future Plans
2.5 Camurus
2.5.1 Camurus Details
2.5.2 Camurus Major Business
2.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Camurus Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Helsinn Holding
2.7.1 Helsinn Holding Details
2.7.2 Helsinn Holding Major Business
2.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Helsinn Holding Recent Developments and Future Plans
2.8 Eisai
2.8.1 Eisai Details
2.8.2 Eisai Major Business
2.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Eisai Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Merck Recent Developments and Future Plans
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product and Solutions
2.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 GlaxoSmithKline Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Postoperative Nausea and Vomiting (PONV) Players Market Share in 2021
3.2.2 Top 10 Postoperative Nausea and Vomiting (PONV) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Postoperative Nausea and Vomiting (PONV) Players Head Office, Products and Services Provided
3.4 Postoperative Nausea and Vomiting (PONV) Mergers & Acquisitions
3.5 Postoperative Nausea and Vomiting (PONV) New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2017-2022)
4.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2017-2022)
5.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2028)
6.2 North America Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2028)
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country
6.3.1 North America Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2028)
6.3.2 United States Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
6.3.3 Canada Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
6.3.4 Mexico Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2028)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2028)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country
7.3.1 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2028)
7.3.2 Germany Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
7.3.3 France Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
7.3.5 Russia Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
7.3.6 Italy Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2028)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2028)
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region
8.3.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Region (2017-2028)
8.3.2 China Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
8.3.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
8.3.4 South Korea Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
8.3.5 India Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
8.3.7 Australia Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2028)
9.2 South America Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2028)
9.3 South America Postoperative Nausea and Vomiting (PONV) Market Size by Country
9.3.1 South America Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2028)
9.3.2 Brazil Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
9.3.3 Argentina Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2028)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2028)
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country
10.3.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2028)
10.3.2 Turkey Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
10.3.4 UAE Postoperative Nausea and Vomiting (PONV) Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Postoperative Nausea and Vomiting (PONV) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Postoperative Nausea and Vomiting (PONV) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Region (2023-2028)
Table 6. Acacia Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Acacia Pharma Major Business
Table 8. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 9. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 13. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 17. Novartis Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Ani Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Ani Pharmaceuticals Major Business
Table 20. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 21. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Camurus Corporate Information, Head Office, and Major Competitors
Table 23. Camurus Major Business
Table 24. Camurus Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 25. Camurus Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Sanofi Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi Major Business
Table 28. Sanofi Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 29. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Helsinn Holding Corporate Information, Head Office, and Major Competitors
Table 31. Helsinn Holding Major Business
Table 32. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 33. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Eisai Corporate Information, Head Office, and Major Competitors
Table 35. Eisai Major Business
Table 36. Eisai Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 37. Eisai Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Merck Corporate Information, Head Office, and Major Competitors
Table 39. Merck Major Business
Table 40. Merck Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 41. Merck Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 43. GlaxoSmithKline Major Business
Table 44. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 45. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Postoperative Nausea and Vomiting (PONV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Postoperative Nausea and Vomiting (PONV) Players Head Office, Products and Services Provided
Table 50. Postoperative Nausea and Vomiting (PONV) Mergers & Acquisitions in the Past Five Years
Table 51. Postoperative Nausea and Vomiting (PONV) New Entrants and Expansion Plans
Table 52. Global Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) by Type (2017-2022)
Table 53. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2017-2022)
Table 54. Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Type (2023-2028)
Table 55. Global Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2022)
Table 56. Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Application (2023-2028)
Table 57. North America Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Postoperative Nausea and Vomiting (PONV) Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Postoperative Nausea and Vomiting (PONV) Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Postoperative Nausea and Vomiting (PONV) Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Postoperative Nausea and Vomiting (PONV) Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Postoperative Nausea and Vomiting (PONV) Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Postoperative Nausea and Vomiting (PONV) Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Postoperative Nausea and Vomiting (PONV) Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Postoperative Nausea and Vomiting (PONV) Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Postoperative Nausea and Vomiting (PONV) Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Postoperative Nausea and Vomiting (PONV) Picture
Figure 2. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type in 2021
Figure 3. Serotonin Antagonists
Figure 4. Steroids
Figure 5. Dopamine Antagonists
Figure 6. NK-1 Receptor Antagonists
Figure 7. Non-pharmacologic Treatment
Figure 8. Others
Figure 9. Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application in 2021
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Retail Pharmacies Picture
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Postoperative Nausea and Vomiting (PONV) Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Region (2017-2028)
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Region in 2021
Figure 17. North America Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Postoperative Nausea and Vomiting (PONV) Market Drivers
Figure 23. Postoperative Nausea and Vomiting (PONV) Market Restraints
Figure 24. Postoperative Nausea and Vomiting (PONV) Market Trends
Figure 25. Acacia Pharma Recent Developments and Future Plans
Figure 26. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Ani Pharmaceuticals Recent Developments and Future Plans
Figure 29. Camurus Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Helsinn Holding Recent Developments and Future Plans
Figure 32. Eisai Recent Developments and Future Plans
Figure 33. Merck Recent Developments and Future Plans
Figure 34. GlaxoSmithKline Recent Developments and Future Plans
Figure 35. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players in 2021
Figure 36. Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2021
Figure 38. Global Top 10 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type in 2021
Figure 41. Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Type (2023-2028)
Figure 42. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application in 2021
Figure 43. Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Application (2023-2028)
Figure 44. North America Postoperative Nausea and Vomiting (PONV) Sales Market Share by Type (2017-2028)
Figure 45. North America Postoperative Nausea and Vomiting (PONV) Sales Market Share by Application (2017-2028)
Figure 46. North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Country (2017-2028)
Figure 47. United States Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Postoperative Nausea and Vomiting (PONV) Sales Market Share by Type (2017-2028)
Figure 51. Europe Postoperative Nausea and Vomiting (PONV) Sales Market Share by Application (2017-2028)
Figure 52. Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Country (2017-2028)
Figure 53. Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Region (2017-2028)
Figure 61. China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Postoperative Nausea and Vomiting (PONV) Sales Market Share by Type (2017-2028)
Figure 68. South America Postoperative Nausea and Vomiting (PONV) Sales Market Share by Application (2017-2028)
Figure 69. South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
